Clinical Trial Update: A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection [Phase 1, Phase 2]

View source ↗

Summary

This document details a Phase 1/2 clinical trial evaluating the efficacy and safety of TQB6411 for injection in patients with advanced lung cancer; the trial st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• TQB6411

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Advanced Lung Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING